Advances in the Treatment of Metastatic Colorectal Cancer

Advances in the Treatment of Metastatic Colorectal Cancer Richard M. Goldberg Oncologist 2005; 10: 40-48 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in gastrointestinal cancer and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Identify the advantages and disadvantages of the various chemotherapeutic regimens used to treat metastatic colorectal cancer. Discuss the emerging role of new agents for the treatment of metastatic colorectal cancer. Discuss the current status of trials of new combination therapies in the treatment of metastatic colorectal cancer. Describe quality of life data for combination chemotherapy for metastatic colorectal cancer and the influence of quality of life on treatment decisions. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Dec. 19, 2005 Most Recent Review: Dec. 19, 2005* Most Recent Update: Dec. 19, 2005 Date Credit Expires: Dec. 19, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.